Patents by Inventor Gustavo Ferrer

Gustavo Ferrer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11759586
    Abstract: A nasal spray bottle with improved nozzle, which has a cap assembly, a nozzle assembly having a flap guidance, a bottle coupling assembly, a dispenser mechanism, and a bottle assembly. The nozzle assembly couples to the bottle coupling assembly, the bottle coupling assembly mounts onto the bottle assembly, and the dispenser mechanism is inside along the nozzle assembly, the bottle coupling assembly, and the bottle assembly. The flap guidance has first and second transversal edges, first and second longitudinal edges, and a central edge. The flap guidance is fixedly attached around the nozzle body by the central edge. The flap guidance is oval shaped. The flap guidance is attached around the nozzle body defining a predetermined angle.
    Type: Grant
    Filed: April 13, 2022
    Date of Patent: September 19, 2023
    Assignee: FERRER MEDICAL INNOVATIONS, LLC
    Inventor: Gustavo Ferrer
  • Patent number: 11426392
    Abstract: Compositions for treatment or prevention of viral infections, such as influenza A and B, coronaviruses, including but not limited to COVID-19 and any variant thereof, and rhinoviruses, along with related treatment methods. Certain compositions according to preferred embodiments may comprise chlorpheniramine and albuterol administered by inhalation in nebulized form.
    Type: Grant
    Filed: April 14, 2021
    Date of Patent: August 30, 2022
    Assignee: FERRER MEDICAL INNOVATIONS, LLC.
    Inventor: Gustavo Ferrer
  • Patent number: 11395819
    Abstract: Compositions for treatment or prevention of viral infections, such as influenza A and B, coronaviruses, including but not limited to COVID-19 and any variant thereof, and rhinoviruses, along with related treatment methods. Certain compositions according to preferred embodiments may comprise chlorpheniramine and albuterol administered by inhalation in nebulized form.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: July 26, 2022
    Assignee: FERRER MEDICAL INNOVATIONS, LLC
    Inventor: Gustavo Ferrer
  • Patent number: 11040162
    Abstract: A representative method includes: providing a tracheostomy valve assembly having a housing and a diaphragm, the housing defining an interior airflow path, the housing having an exterior surface, a distal opening extending from the exterior surface to the interior flow path and a proximal opening, the distal opening and the proximal opening communicating with the interior airflow path, the diaphragm being disposed within the housing along the interior airflow path, the diaphragm being biased to a closed position to prevent air from passing the diaphragm along the interior airflow path, the diaphragm being configured to selectively move to an open position to enable air to be drawn into the distal opening, passed the diaphragm, and out of the proximal opening in an inhaling direction in response to a proximal side of the diaphragm being exposed to a predetermined negative air pressure applied at the diaphragm as a suction force; and urging the diaphragm away from the closed position with an actuation surface, m
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: June 22, 2021
    Inventor: Gustavo Ferrer
  • Patent number: 10874650
    Abstract: Compositions for treatment or prevention of viral infections, such as influenza A and B, coronaviruses, including but not limited to COVID-19, and rhinoviruses, along with related treatment methods. Certain compositions according to preferred embodiments of the invention may comprise chlorpheniramine, xylitol, and other inactive ingredients, such as aloe vera and/or grapefruit seed extract.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: December 29, 2020
    Inventor: Gustavo Ferrer
  • Publication number: 20200261433
    Abstract: Compositions for treatment of various nasal and/or sinus conditions, such as sinusitis, rhinitis, nasal drip, coughing, sneezing, cold, influenza, viral infections, and the like, along with related treatment methods. Certain compositions according to preferred embodiments of the invention may comprise one or more antihistamines, one or more corticosteroids, and xylitol. Some embodiments may further comprise aloe vera and/or various other optional ingredients, such as benzalkonium chloride and/or grapefruit seed extract.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 20, 2020
    Inventor: Gustavo Ferrer
  • Publication number: 20190070376
    Abstract: A representative method includes: providing a tracheostomy valve assembly having a housing and a diaphragm, the housing defining an interior airflow path, the housing having an exterior surface, a distal opening extending from the exterior surface to the interior flow path and a proximal opening, the distal opening and the proximal opening communicating with the interior airflow path, the diaphragm being disposed within the housing along the interior airflow path, the diaphragm being biased to a closed position to prevent air from passing the diaphragm along the interior airflow path, the diaphragm being configured to selectively move to an open position to enable air to be drawn into the distal opening, passed the diaphragm, and out of the proximal opening in an inhaling direction in response to a proximal side of the diaphragm being exposed to a predetermined negative air pressure applied at the diaphragm as a suction force; and urging the diaphragm away from the closed position with an actuation surface, m
    Type: Application
    Filed: September 7, 2018
    Publication date: March 7, 2019
    Inventor: Gustavo Ferrer